Filing Details
- Accession Number:
- 0001179110-14-004476
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-03-05 14:50:59
- Reporting Period:
- 2014-02-14
- Filing Date:
- 2014-03-05
- Accepted Time:
- 2014-03-05 14:50:59
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 882095 | Gilead Sciences Inc | GILD | Biological Products, (No Disgnostic Substances) (2836) | 943047598 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1334682 | H Gregg Alton | Gilead Sciences, Inc. 333 Lakeside Drive Foster City CA 94404 | Evp, Corp & Med Affairs | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-02-14 | 968 | $21.94 | 86,484 | No | 5 | A | Direct | |
| Common Stock | Acquisiton | 2014-03-03 | 31,000 | $21.58 | 117,484 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-03-03 | 27,069 | $81.76 | 90,415 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-03-03 | 3,931 | $82.36 | 86,484 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-03-03 | 1,500 | $81.66 | 84,984 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-03-03 | 500 | $82.53 | 84,484 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 5 | A | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2014-03-03 | 31,000 | $0.00 | 31,000 | $21.58 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 27,367 | 2018-01-30 | No | 4 | M | Direct |
Footnotes
- The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.
- The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant. The balance will vest 5% quarterly thereafter until fully vested.
- Sale prices reported for the transactions reported here range from $81.04 to $82.03. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
- Sale prices reported for the transactions reported here range from $82.04 to $82.83. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
- Sale prices reported for the transactions reported here range from $81.12 to $82.08. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
- Sale prices reported for the transactions reported here range from $82.23 to $82.80. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
- Shares were acquired under the Gilead Sciences, Inc. Employee Stock Purchase Plan.
Billionaire Hedge Funds
